![Gillian Cannon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 87 824 $ al 30/06/2026
Gillian M.
Cannon is currently Director at Affibody AB since 2019, Independent Director at Xenon Pharmaceuticals, Inc. since 2023, and Director at Edinburgh Innovations Ltd. since 2020.
Former roles include Independent Director at Corcept Therapeutics, Inc. from 2020 to 2025, President-North American Operations at UCB, Inc. from 2015 to 2017, Vice President-Commercial Operations at Merck BioVentures from 2008 to 2012, President at Alyvant, Inc., and Head-Commercial Innovation at Roivant Sciences, Inc. from 2020 to 2024.
Education includes undergraduate studies at The University of Edinburgh and doctorates from Temple University (Pennsylvania) and Fox School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/06/2026 | 1.455 ( 0 % ) | 87 824 $ | 30/06/2026 | |
| 10/09/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Director/Miembro de la Junta | 08/08/2023 |
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Director/Miembro de la Junta | 01/01/2019 |
Edinburgh Innovations Ltd.
 Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research support services | Director/Miembro de la Junta | 01/01/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Director/Miembro de la Junta | 10/10/2025 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Corporate Officer/Principal | 01/04/2024 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01/01/2017 |
Merck BioVentures | Corporate Officer/Principal | 01/01/2012 |
Alyvant, Inc.
 Alyvant, Inc. Part of Roivant Sciences Ltd., Alyvant, Inc. is a biotechnology company that aims to improve the lives of patients by accelerating the development and commercialization of meaningful medicines. The company is based in New York, NY. | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Edinburgh Innovations Ltd.
Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research support services | Commercial Services |
Fox School of Business
 Fox School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck BioVentures | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Alyvant, Inc.
Alyvant, Inc. Part of Roivant Sciences Ltd., Alyvant, Inc. is a biotechnology company that aims to improve the lives of patients by accelerating the development and commercialization of meaningful medicines. The company is based in New York, NY. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
